[Primay hyperaldosteronism--diagnostic and treatment]
- PMID: 23168980
- DOI: 10.1055/s-0032-1327318
[Primay hyperaldosteronism--diagnostic and treatment]
Abstract
Primary hyperaldosteronism (PHA) is characterized by an increased Aldosterone synthesis which is independent of the Renin-Angiotensin-Aldosterone-System (RAAS). The prevalence of PHA in patients who present in specialized hypertension centers is approx. 10 %. Besides patients with the classical symptoms known as "Conn-Trias" (hypertension, hypokalemia, metabolic alkalosis), the more frequent normokalemic patients with PHA also show a worse outcome compared to patients with essential hypertension. Identifying these patients is an important task in the evaluation of hypertension since targeted treatment options are available. Screening for PHA using the Aldosterone-Renin-Ratio (ARR) should be performed in patients with hypokalemic, severe or resistant hypertension. In addition, young patients with early onset of severe hypertension and/or positive family history should be screened. A positive screening result should be followed by a confirmatory test. The saline infusion test is the preferred clinical test for confirming a suspected PHA since it is accessible and time efficient. Other confirmatory tests are not used on a regular basis. After any confirmatory test, CT- or MRI-imaging and adrenal vein sampling (AVS) is used in order to differentiate between a unilateral adenoma, a bilateral hyperplasia or another cause of PHA. CT or MRI usually cannot discriminate smaller tumors form hyperplasia. Therefore AVS is used to detect lateralization of autonomous aldosterone production. Lateralization of aldosterone production indicates a unilateral adenoma. In these cases, laparoscopic adrenalectomy is the therapeutic option of choice with a hypertension cure rate of up to 60 %. If no lateralization is detectable, bilateral hyperplasia as the underlying cause of PHA is likely. Pharmacological inhibition of the mineralocorticoid receptor is the preferred treatment option in these cases. If Spironolactone is not well tolerated, Eplerenone and potassium-sparing diuretics should be prescribed. Often, however, in order to fully control hypertension, additional antihypertensive therapy is necessary.
© Georg Thieme Verlag KG Stuttgart · New York.
Similar articles
-
[Comparison of adrenal imaging and selective adrenal vein sampling in primary hyperaldosteronism].Dtsch Med Wochenschr. 2007 Nov;132(46):2436-41. doi: 10.1055/s-2007-991669. Dtsch Med Wochenschr. 2007. PMID: 17987550 German.
-
[Modern pharmacological aspects of hyperaldosteronism therapy].Internist (Berl). 2006 Sep;47(9):953-9. doi: 10.1007/s00108-006-1681-0. Internist (Berl). 2006. PMID: 16823578 Review. German.
-
Primary hyperaldosteronism due to adrenal microadenoma: a curable cause of refractory hypertension.J Renin Angiotensin Aldosterone Syst. 2008 Jun;9(2):103-6. doi: 10.3317/jraas.2008.015. J Renin Angiotensin Aldosterone Syst. 2008. PMID: 18584586
-
Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism.Semin Nephrol. 2013 May;33(3):265-76. doi: 10.1016/j.semnephrol.2013.04.007. Semin Nephrol. 2013. PMID: 23953804 Free PMC article. Review.
-
[Primary hyperaldosteronisms: from diagnosis to treatment].Presse Med. 2009 Apr;38(4):633-42. doi: 10.1016/j.lpm.2009.01.009. Epub 2009 Mar 18. Presse Med. 2009. PMID: 19299107 Review. French.
Cited by
-
A Normotensive Patient with Primary Aldosteronism.Case Rep Endocrinol. 2017;2017:5159382. doi: 10.1155/2017/5159382. Epub 2017 Apr 2. Case Rep Endocrinol. 2017. PMID: 28469946 Free PMC article.
-
[Heart and kidneys. Renal denervation as therapy for hypertension].Herz. 2013 Feb;38(1):67-75; quiz 76-8. doi: 10.1007/s00059-012-3752-4. Herz. 2013. PMID: 23377236 German.
-
Proportion of Patients With Hypertension Resolution Following Adrenalectomy for Primary Aldosteronism: A Systematic Review and Meta-Analysis.J Clin Hypertens (Greenwich). 2016 Dec;18(12):1205-1212. doi: 10.1111/jch.12916. Epub 2016 Oct 19. J Clin Hypertens (Greenwich). 2016. PMID: 27759187 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical